Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes (2 years).

Although no significant differences were observed at 2 years, the Magmaris cohort showed a borderline significant primary endpoint reduction (5.1% vs. 11% respectively, p = 0.051).

also in 11,409 other papers

The log-rank test was used to evaluate the primary outcome survival curve; the p -value did not reach statistical significance ( p = 0.052).

also in 111,027 other papers